Comment on “Exploring PD-1 methylation in oral cancer: A crucial frontier in immunotherapy”

Comment on “Exploring PD-1 methylation in oral cancer: A crucial frontier in immunotherapy”

Saved in:

Bibliographic Details
Main Author:	Muthupandian Saravanan
Format:	Article
Language:	English
Published:	Elsevier 2024-09-01
Series:	Oral Oncology Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772906024004047
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Exploring PD-1 methylation in oral cancer: A crucial frontier in immunotherapy
by: Prasad Monisha, et al.
Published: (2024-03-01)

Targeting Exosomal PD-L1 as a New Frontier in Cancer Immunotherapy
by: Laura Denisa Dragu, et al.
Published: (2025-07-01)

Comment on ‘exploring prognostic factors for survival in patients with advanced pancreatic cancer undergoing PD-1 inhibitor immunotherapy’
by: Jiaqing Wang, et al.
Published: (2024-12-01)

Comment on “TGM3 - A novel biomarker as a potential diagnostic target for head and neck squamous cell carcinoma (HNSCC)”
by: Muthupandian Saravanan
Published: (2024-09-01)

Advancements in cancer research: 3D bioprinting as an optimal oral tumor model
by: Aruchamy Mohanprasanth, et al.
Published: (2024-03-01)

Clinical Implications of Exosomal PD-L1 in Cancer Immunotherapy
by: Sergio Ayala-Mar, et al.
Published: (2021-01-01)

Basic rules to respond to PD-1 blockade cancer immunotherapy
by: Antoni Ribas
Published: (2025-05-01)

Exploring prognostic factors for survival in patients with advanced pancreatic cancer undergoing PD-1 inhibitor immunotherapy
by: Yue Ma, et al.
Published: (2024-12-01)

The Crucial Role of Smoking Cessation in Preventing Oral Cancer
by: Prabhu Manickam Natarajan, et al.
Published: (2024-12-01)

Candida albicans overgrowth impairs anti-PD-1 immunotherapy in oral tumor-bearing mice
by: Xu Wang, et al.
Published: (2025-08-01)

SERPINA1 is a new frontier in cancer immunotherapy and drug targeting by pan-cancer analysis
by: Chen Fu, et al.
Published: (2025-06-01)

Methylation testing: is this the new frontier in cervical cancer screening?
by: Anca Potecă, et al.
Published: (2024-01-01)

An updated review of immunotherapy in esophageal cancer: PD-L1 footprint
by: Juan Yao, et al.
Published: (2024-05-01)

Targeting PD-1 post-translational modifications for improving cancer immunotherapy
by: Jie Shi, et al.
Published: (2025-06-01)

The potential role of HPV oncoproteins in the PD-L1/PD-1 pathway in cervical cancer: new perspectives on cervical cancer immunotherapy
by: Jin Li, et al.
Published: (2024-12-01)

Unraveling the Role of the Microbiota in Cancer Immunotherapy: A New Frontier
by: Shouliang Wang, et al.
Published: (2025-01-01)

Metabolism of tryptophan in non-small lung cancer patients with different effect of PD-1 / PD-L1 inhibitors immunotherapy
by: E. Yu. Zlatnik, et al.
Published: (2022-06-01)

Role of PD-1/PD-L1 signaling axis in oncogenesis and its targeting by bioactive natural compounds for cancer immunotherapy
by: Yogesh Godiyal, et al.
Published: (2024-12-01)

TIM-3 teams up with PD-1 in cancer immunotherapy: mechanisms and perspectives
by: Zhuohong Yan, et al.
Published: (2025-05-01)

Theoretical investigation on PD-L1-In-1 for cancer immunotherapy via density functional theory
by: Bijay Sijapati Magar, et al.
Published: (2025-08-01)

Knowledge-map analysis and bladder cancer immunotherapy: Comment
by: Hinpetch Daungsupawong, et al.
Published: (2023-12-01)

Methyl Jasmonate Acts as a Crucial Player in Abiotic Stress Responses in Grape
by: Abdul Hakeem, et al.
Published: (2025-06-01)

Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors
by: Yi Duan, et al.
Published: (2022-03-01)

Dissecting the link between PD-1/PD-L1-based immunotherapy and cancer pain: mechanisms, research implications, and artificial intelligence perspectives
by: Marco Cascella, et al.
Published: (2024-12-01)

Utilizing Nanoparticles to Overcome Anti-PD-1/PD-L1 Immunotherapy Resistance in Non-Small Cell Lung cancer: A Potential Strategy
by: Ge Y, et al.
Published: (2025-02-01)

Blockade of CLEVER-1 restrains immune evasion and enhances anti-PD-1 immunotherapy in gastric cancer
by: Tianwei Xu, et al.
Published: (2025-05-01)

Spatial Heterogeneity of Intratumoral Microbiota: A New Frontier in Cancer Immunotherapy Resistance
by: Qiwen Tan, et al.
Published: (2025-05-01)

Reply to “Knowledge-map analysis and bladder cancer immunotherapy: Comment”
by: Zongwei Lv, et al.
Published: (2024-12-01)

The crucial role of SPP1 in osteoporosis, osteoarthritis, and cancer
by: Yaru Qu, et al.
Published: (2025-12-01)

Effects of chemoradiotherapy on surface PD-L1 expression in esophageal cancer and its implications for immunotherapy
by: Lovis Hampe, et al.
Published: (2024-12-01)

FXR agonist GW4064 enhances anti-PD-L1 immunotherapy in colorectal cancer
by: Lu Lu, et al.
Published: (2023-12-01)

Correction: Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors
Published: (2025-04-01)

Exploring Bacteria‐Based Cancer Immunotherapy: Comment on “Discovery of Intratumoral Oncolytic Bacteria Toward Targeted Anticancer Theranostics”
by: Chen‐xi Li, et al.
Published: (2025-08-01)

Efficacy and Safety of Paclitaxel-Based PD-1/PD-L1 Immunotherapies for Triple-Negative Breast Cancer: A Systematic Review and Network Meta-Analysis
by: Youran Dai, et al.
Published: (2024-12-01)

Current perspectives on tertiary lymphoid structures and PD-1/PD-L1 signaling pathway in the immunotherapy of hepatocellular carcinoma
by: Hao-Dong QIAO, et al.
Published: (2023-10-01)

Fluorinated small molecule derivatives in cancer immunotherapy: emerging frontiers and therapeutic potential
by: Ka Fai Leong, et al.
Published: (2025-07-01)

Rewiring lipid metabolism to enhance immunotherapy efficacy in melanoma: a frontier in cancer treatment
by: Lihua Xiong, et al.
Published: (2025-05-01)

Mechanisms of Resistance to Anti-PD-1 Immunotherapy in Melanoma and Strategies to Overcome It
by: Magdalena K. Zielińska, et al.
Published: (2025-02-01)

Enhanced cancer immunotherapy via synergistic action of NO-Donor nanoparticles (NanoARG) and PD-1 antibody
by: Ting Mei, et al.
Published: (2025-12-01)

Multimodal deep learning for predicting PD-L1 biomarker and clinical immunotherapy outcomes of esophageal cancer
by: Hui Liu, et al.
Published: (2025-03-01)